| Sur un cas d'agrypnie (4 mois sans sommeil) au cours d'une maladie de Morvan. Effet favorable du 5-hydroxytryptophane |
| C. Fischer-Perroudon, J. Mouret et M. Jouvet Electroencephalography and Clinical Neurophysiology, 1974, 36: 1-18 |
| IMPRESSION |
| Version imprimable (Tout l'article dans une seule page) |
Figure 4 : Correlation between the duration of stages III and IV
Above: Correlation between the duration of stages III and IV (in minutes per night, ordinates) and the concentration of 5-HIAA in the urine excretion during the same day (in mg per 1000 ml) (abcissae); scales in 100 mg. r = 0.9114, n = 44, P < 0.001./p>
Below: Correlation between stage III and IV and the dose of DL-5-HTP given during the same day (abcissae); dose in grams. r = 0.6099, n = 54, P < 0.001